CO5090903A1 - Nuevos peptidos para ser usados en una terapia de tolerancia inducida para impedir las alteraciones autoinmunes, en particular, artritis reumatoidea - Google Patents
Nuevos peptidos para ser usados en una terapia de tolerancia inducida para impedir las alteraciones autoinmunes, en particular, artritis reumatoideaInfo
- Publication number
- CO5090903A1 CO5090903A1 CO99046229A CO99046229A CO5090903A1 CO 5090903 A1 CO5090903 A1 CO 5090903A1 CO 99046229 A CO99046229 A CO 99046229A CO 99046229 A CO99046229 A CO 99046229A CO 5090903 A1 CO5090903 A1 CO 5090903A1
- Authority
- CO
- Colombia
- Prior art keywords
- seq
- amino acid
- alterations
- rheumatoid arthritis
- new peptides
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 230000004075 alteration Effects 0.000 title 1
- 230000001363 autoimmune Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 206010039073 rheumatoid arthritis Diseases 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 abstract 1
- 101100505161 Caenorhabditis elegans mel-32 gene Proteins 0.000 abstract 1
- IAYPZSHNZQHQNO-KKUMJFAQSA-N His-Ser-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CN=CN2)N IAYPZSHNZQHQNO-KKUMJFAQSA-N 0.000 abstract 1
- KLYYKKGCPOGDPE-OEAJRASXSA-N Phe-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O KLYYKKGCPOGDPE-OEAJRASXSA-N 0.000 abstract 1
- SRTCFKGBYBZRHA-ACZMJKKPSA-N Ser-Ala-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SRTCFKGBYBZRHA-ACZMJKKPSA-N 0.000 abstract 1
- BVOVIGCHYNFJBZ-JXUBOQSCSA-N Thr-Leu-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O BVOVIGCHYNFJBZ-JXUBOQSCSA-N 0.000 abstract 1
- LECUEEHKUFYOOV-ZJDVBMNYSA-N Thr-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)[C@@H](C)O LECUEEHKUFYOOV-ZJDVBMNYSA-N 0.000 abstract 1
- 108010005233 alanylglutamic acid Proteins 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Rehabilitation Therapy (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Péptido CARACTERIZADO porque tiene una secuencia de amino ácidos de 9-55 residuos de aminoácidos que comprende la secuencia de amino ácidos FTLASAETT (SEQ ID No. 1).(2) INFORMACIÓN PARA SEQ ID NO: 1:(i) CARACTERÍSTICAS DE LA SECUENCIA:(A) LONGITUD: 9 amino ácidos(B) TIPO: amino ácido(C) HEBRAS: una(D) TOPOLOGÍA: lineal(ii) TIPO DE MOLÉCULA: péptido(xi) DESCRIPCIÓN DE LA SECUENCIA: SEQ ID NO: 1:Phe Thr Leu Ala Ser Ala Glu Thr Thr1 5(2) INFORMACIÓN PARA SEQ ID NO: 2:(i) CARACTERÍSTICAS DE LA SECUENCIA:(A) LONGITUD: 13 amino ácidos(B) TIPO: amino ácido(C) HEBRAS: una(D) TOPOLOGÍA: lineal(ii) TIPO DE MOLÉCULA: péptido(xi) DESCRIPCIÓN DE LA SECUENCIA: SEQ ID NO: 2:His Ser Phe Thr Leu Ala Ser Ala Glu Thr Thr Val Gly1 5 10
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98202470 | 1998-07-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5090903A1 true CO5090903A1 (es) | 2001-10-30 |
Family
ID=8233961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO99046229A CO5090903A1 (es) | 1998-07-23 | 1999-07-22 | Nuevos peptidos para ser usados en una terapia de tolerancia inducida para impedir las alteraciones autoinmunes, en particular, artritis reumatoidea |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6964766B1 (es) |
| EP (1) | EP1100823A2 (es) |
| JP (1) | JP2002521388A (es) |
| KR (1) | KR20010071020A (es) |
| CN (1) | CN1310724A (es) |
| AU (1) | AU758310B2 (es) |
| BR (1) | BR9912378A (es) |
| CA (1) | CA2334947A1 (es) |
| CO (1) | CO5090903A1 (es) |
| CZ (1) | CZ2001286A3 (es) |
| HU (1) | HUP0103384A3 (es) |
| ID (1) | ID27998A (es) |
| IL (1) | IL140825A0 (es) |
| NO (1) | NO20010355L (es) |
| NZ (1) | NZ509417A (es) |
| PE (1) | PE20000931A1 (es) |
| PL (1) | PL345958A1 (es) |
| RU (1) | RU2233290C2 (es) |
| SK (1) | SK1042001A3 (es) |
| TR (1) | TR200100175T2 (es) |
| WO (1) | WO2000005254A2 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7265208B2 (en) | 2001-05-01 | 2007-09-04 | The Regents Of The University Of California | Fusion molecules and treatment of IgE-mediated allergic diseases |
| HUP0400659A3 (en) | 2001-07-24 | 2005-06-28 | Zhu Zhou Woodbridge | Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| CN1169829C (zh) * | 2002-06-27 | 2004-10-06 | 北京大学人民医院 | 非t细胞结合肽及其用途 |
| RU2667423C1 (ru) * | 2017-06-28 | 2018-09-19 | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ПраймБиоМед" | Мышиная гибридома ykl-39, клон 1b2 g4 - продуцент моноклонального антитела, обладающего специфичностью к цитоплазматическому антигену ykl-39 человека |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL115744A (en) * | 1994-10-27 | 2000-07-16 | Akzo Nobel Nv | Peptides comprising a subsequence of human cartilage glycoprotein - 39 |
| TW575583B (en) * | 1996-04-24 | 2004-02-11 | Akzo Nobel Nv | Novel peptides suitable for use in antigen specific immunosuppressive therapy |
| EP0805206A3 (en) | 1996-05-03 | 1999-09-15 | Smithkline Beecham Corporation | Human cartilage glycoprotein |
| WO1998006859A1 (en) | 1996-08-09 | 1998-02-19 | Human Genome Sciences, Inc. | Human chitinase alpha and chitinase alpha-2 |
-
1999
- 1999-07-16 PL PL99345958A patent/PL345958A1/xx not_active Application Discontinuation
- 1999-07-16 KR KR1020017000992A patent/KR20010071020A/ko not_active Application Discontinuation
- 1999-07-16 SK SK104-2001A patent/SK1042001A3/sk unknown
- 1999-07-16 CA CA002334947A patent/CA2334947A1/en not_active Abandoned
- 1999-07-16 BR BR9912378-9A patent/BR9912378A/pt not_active IP Right Cessation
- 1999-07-16 US US09/744,170 patent/US6964766B1/en not_active Expired - Fee Related
- 1999-07-16 CN CN99808862A patent/CN1310724A/zh active Pending
- 1999-07-16 TR TR2001/00175T patent/TR200100175T2/xx unknown
- 1999-07-16 RU RU2001105086/04A patent/RU2233290C2/ru not_active IP Right Cessation
- 1999-07-16 NZ NZ509417A patent/NZ509417A/xx unknown
- 1999-07-16 JP JP2000561210A patent/JP2002521388A/ja not_active Withdrawn
- 1999-07-16 IL IL14082599A patent/IL140825A0/xx unknown
- 1999-07-16 CZ CZ2001286A patent/CZ2001286A3/cs unknown
- 1999-07-16 ID IDW20010192A patent/ID27998A/id unknown
- 1999-07-16 AU AU54112/99A patent/AU758310B2/en not_active Ceased
- 1999-07-16 EP EP99940012A patent/EP1100823A2/en not_active Withdrawn
- 1999-07-16 HU HU0103384A patent/HUP0103384A3/hu unknown
- 1999-07-16 WO PCT/EP1999/005050 patent/WO2000005254A2/en not_active Application Discontinuation
- 1999-07-21 PE PE1999000730A patent/PE20000931A1/es not_active Application Discontinuation
- 1999-07-22 CO CO99046229A patent/CO5090903A1/es unknown
-
2001
- 2001-01-22 NO NO20010355A patent/NO20010355L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TR200100175T2 (tr) | 2001-09-21 |
| BR9912378A (pt) | 2001-04-17 |
| HUP0103384A3 (en) | 2004-06-28 |
| RU2001105086A (ru) | 2004-01-20 |
| NO20010355D0 (no) | 2001-01-22 |
| PE20000931A1 (es) | 2000-09-16 |
| US6964766B1 (en) | 2005-11-15 |
| JP2002521388A (ja) | 2002-07-16 |
| NO20010355L (no) | 2001-03-20 |
| ID27998A (id) | 2001-05-03 |
| SK1042001A3 (en) | 2001-09-11 |
| IL140825A0 (en) | 2002-02-10 |
| CZ2001286A3 (en) | 2001-08-15 |
| AU758310B2 (en) | 2003-03-20 |
| KR20010071020A (ko) | 2001-07-28 |
| WO2000005254A2 (en) | 2000-02-03 |
| AU5411299A (en) | 2000-02-14 |
| WO2000005254A3 (en) | 2000-06-15 |
| PL345958A1 (en) | 2002-01-14 |
| HUP0103384A2 (hu) | 2001-12-28 |
| RU2233290C2 (ru) | 2004-07-27 |
| CN1310724A (zh) | 2001-08-29 |
| CA2334947A1 (en) | 2000-02-03 |
| EP1100823A2 (en) | 2001-05-23 |
| NZ509417A (en) | 2003-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE368053T1 (de) | Antimikrobielle peptide | |
| AR015977A1 (es) | Variantes de proteasa multiplemente substituida con carga neta alterada para su empleo en detergentes | |
| ES2169251T3 (es) | Peptidos de somatostatina. | |
| NO960939L (no) | Kininogenaseinhibitor | |
| DE69827262D1 (de) | Penaeidine: antimikrobielle peptide aus krebstieren | |
| AR002742A1 (es) | Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn | |
| CO5090903A1 (es) | Nuevos peptidos para ser usados en una terapia de tolerancia inducida para impedir las alteraciones autoinmunes, en particular, artritis reumatoidea | |
| AU2001231881A1 (en) | Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and theuse thereof in the synthesis of synthetic proteins and polypeptides | |
| CY1109946T1 (el) | Τροποποιημενα πεπτιδια και η χρηση τους για τη θεραπεια αυτοανοσων νοσων | |
| PT728208E (pt) | Endo-transglicosilase para o xiloglucano do tomate | |
| DE602004028266D1 (de) | Angiogene peptide und ihre verwendungen | |
| ATE362769T1 (de) | Lineare kationische peptide mit fungizider wirksamkeit | |
| PE20000177A1 (es) | GEN dtsR TERMOSENSIBLE | |
| ES2112921T3 (es) | Peptidos y anticuerpos para el tratamiento de la artritis reumatoide. | |
| HUP0203504A2 (hu) | Immunterápiás alkalmazásra szolgáló módosított peptidek és peptid-mimetikumok | |
| EA200100314A1 (ru) | Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины | |
| CO4700528A1 (es) | Peptidos de somatostatina | |
| DE69831584T2 (de) | Polypeptide mit wasserkanalaktivität und dna sequenzen | |
| SE9700301D0 (sv) | New compound | |
| DK0779297T3 (da) | Antigene peptider med glycinsubstitutioner | |
| ATE393224T1 (de) | Nukleinsäuresequenzen von hyperplasien und tumoren der schilddrüse | |
| BR9709205A (pt) | Polipeptìdeos processados com arividade de il-16, processos para a sua produção e seu uso | |
| ATE283914T1 (de) | Iga1-protease fragment als trägerpeptid | |
| CO4340568A1 (es) | Familia de peptidos con 51 aminoacidos en longitud, secuen- cias de definicion, la planta transgenica comprendida, el vector de expresion recombinante y el metodo para su pro- duccion. | |
| ECSP961798A (es) | Peptidos de somatostatina |